46-60 of 213
Reimagining Autoimmune Care with CAR-Based Cell Therapies
Living RheumReimagining Autoimmune Care with CAR-Based Cell Therapies
Reframing Sjögren’s Syndrome: Insights from a Comprehensive Review
Living RheumReframing Sjögren’s Syndrome: Insights from a Comprehensive Review
Topical Cell-Free Therapy for Psoriasis: A Sponge-Based Secretome Formulation
Clinician's RoundtableTopical Cell-Free Therapy for Psoriasis: A Sponge-Based Secretome Formulation
Efgartigimod Shows Early Promise for Primary Sjögren’s Disease
Living RheumEfgartigimod Shows Early Promise for Primary Sjögren’s Disease
Unmasking Patient Subtypes in Sjögren’s Disease to Enable Personalized Care
Living RheumUnmasking Patient Subtypes in Sjögren’s Disease to Enable Personalized Care
Targeting Inflammation to Improve Gene Therapy Outcomes in Sickle Cell Disease
Clinician's RoundtableTargeting Inflammation to Improve Gene Therapy Outcomes in Sickle Cell Disease
- advertisement
FPIES in Infants: Optimizing Care and Addressing Complications
On the Frontlines of Food AllergiesFPIES in Infants: Optimizing Care and Addressing Complications
Care Considerations forIgE-Positive Food Protein-Induced Enterocolitis Syndrome
On the Frontlines of Food AllergiesCare Considerations forIgE-Positive Food Protein-Induced Enterocolitis Syndrome
Navigating Diagnostic Challenges in Food Protein-Induced Enterocolitis Syndrome
On the Frontlines of Food AllergiesNavigating Diagnostic Challenges in Food Protein-Induced Enterocolitis Syndrome
Moderna’s 2024–2025 COVID-19 Vaccine: Composition Updates and Interim Effectiveness Data
Clinician's RoundtableModerna’s 2024–2025 COVID-19 Vaccine: Composition Updates and Interim Effectiveness Data
Managing Food Allergies with Oral Immunotherapy: Benefits and Considerations
On the Frontlines of Food AllergiesManaging Food Allergies with Oral Immunotherapy: Benefits and Considerations
Assessing Milk and Egg Ladders for Pediatric IgE-Mediated Allergies
On the Frontlines of Food AllergiesAssessing Milk and Egg Ladders for Pediatric IgE-Mediated Allergies
- advertisement
An Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
Spotlight On Subcutaneous Cancer ImmunotherapiesAn Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
Nanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
Spotlight On Subcutaneous Cancer ImmunotherapiesNanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
Evaluating Alemtuzumab in Adult ALL: Insights from a Phase 1/2 Clinical Trial
Project Oncology®Evaluating Alemtuzumab in Adult ALL: Insights from a Phase 1/2 Clinical Trial





























